Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $2,361.0M | $4,044.0M | $4,171.0M | $4,134.0M | $5,316.0M | $5,806.0M | $5,207.0M | $4,552.0M | $5,193.0M | $5,598.0M | $7,552.0M | $8,428.0M | $9,517.0M | $10.5B | $10.6B | $8,532.0M | $9,889.0M | $8,381.0M | $8,785.0M | $7,359.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Amgen Inc.'s last 12-month Free Cash Flow is $6,283.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Amgen Inc.'s Free Cash Flow growth was (33.0%). The average annual Free Cash Flow growth rates for Amgen Inc. have been (13.9%) over the past three years, (7.3%) over the past five years.
Over the last year, Amgen Inc.'s Free Cash Flow growth was (33.0%), which is lower than industry growth of (0.2%). It indicates that Amgen Inc.'s Free Cash Flow growth is Bad.